Clearance Summary
MODIFIED AMERLEX-M PROGESTERONE RADIOIMMUNO. KIT received FDA 510(k) clearance under submission number K880934, sponsored by Amersham Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1988-04-18.
- Submission: K880934
- Applicant / Sponsor: Amersham Corp.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1620
- Decision date: 1988-04-18
Classification & Regulation
This clearance is catalogued under FDA product code JLS and 21 CFR 862.1620, within the Clinical Chemistry review panel as a Class I device.